Evidence map›Paper›PMID 24005224›Full record

ArticleKidney international2014

Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery.

John M Arthur, Elizabeth G Hill, Joseph L Alge, Evelyn C Lewis, Benjamin A Neely, Michael G Janech, James A Tumlin, Lakhmir S Chawla, Andrew D Shaw, SAKInet Investigators

Open access · bronzeAbstract readComparative StudyEvaluation StudyMulticenter Study
In one paragraph

Article in Kidney international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 166 citations in OpenAlex.

  1. Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.Journal of the American Society of Nephrology : JASN · 2015
    Trial
  2. Trial
  3. Trial
  4. Review
  5. Protective Effects and Mechanisms of Extracellular Vesicles in Remote Ischemic Preconditioning on Renal Injury Induced by Inflammation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  6. Proteomic Characterization of Bottlenose Dolphin (Journal of proteome research · 2026
    Article
  7. Article
  8. Observational
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. The Utility of Novel Kidney Injury Biomarkers in Early Detection of CSA-AKI.International journal of molecular sciences · 2022
    Article
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

John M Arthur1] Medical Service, Ralph H Johnson VA Medical Center, Charleston, South Carolina, USA [2] Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Elizabeth G HillDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Joseph L AlgeDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Evelyn C LewisDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Benjamin A NeelyDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Michael G Janech1] Medical Service, Ralph H Johnson VA Medical Center, Charleston, South Carolina, USA [2] Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
James A TumlinDepartment of Medicine, University of Tennessee, Chattanooga, Tennessee, USA.
Lakhmir S ChawlaDepartments of Medicine and Anesthesiology and Critical Care Medicine, George Washington University, Washington, District of Columbia, USA.
Andrew D Shaw1] Department of Anesthesiology, Durham VA Medical Center, Durham, North Carolina, USA [2] Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.
SAKInet Investigators
Medical University of South Carolina · USDuke Medical Center · USGeorge Washington University · USUniversity of Tennessee at Chattanooga · US

Funding

SOUTH CAROLINA CLINICAL & TRANSLATIONAL RESEARCH INSTITUTE (SCTR)UL1RR029882 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2009 to 2011
$10.1M
Prognostic markers in postoperative acute kidney injuryR01DK080234 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ARTHUR, JOHN M. · 2008 to 2011
$1.5M
South Carolina Clinical & Translational Research Institute (SCTR)TL1RR029881 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2009 to 2011
$1.1M
NCRR NIH HHS TL1 RR029881NCRR NIH HHS UL1 RR029882NIDDK NIH HHS R01 DK080234NIDDK NIH HHS R01DK080234
6 · The paper itself

Abstract

Biomarkers for acute kidney injury (AKI) have been used to predict the progression of AKI, but a systematic comparison of the prognostic ability of each biomarker alone or in combination has not been performed. In order to assess this, we measured the concentration of 32 candidate biomarkers in the urine of 95 patients with AKIN stage 1 after cardiac surgery. Urine markers were divided into eight groups based on the putative pathophysiological mechanism they reflect. We then compared the ability of the markers alone or in combination to predict the primary outcome of worsening AKI or death (23 patients) and the secondary outcome of AKIN stage 3 or death (13 patients). IL-18 was the best predictor of both outcomes (AUC of 0.74 and 0.89). L-FABP (AUC of 0.67 and 0.85), NGAL (AUC of 0.72 and 0.83), and KIM-1 (AUC of 0.73 and 0.81) were also good predictors. Correlation between most of the markers was generally related to their predictive ability, but KIM-1 had a relatively weak correlation with other markers. The combination of IL-18 and KIM-1 had a very good predictive value with an AUC of 0.93 to predict AKIN 3 or death. Thus, a combination of IL-18 and KIM-1 would result in improved identification of high-risk patients for enrollment in clinical trials.

Indexed as

Acute Kidney InjuryAdultAgedAged, 80 and overArea Under CurveBiomarkersCardiac Surgical ProceduresDisease ProgressionFemaleHepatitis A Virus Cellular Receptor 1HumansInterleukin-18MaleMembrane GlycoproteinsMiddle AgedPredictive Value of TestsBiomarkersHAVCR1 protein, humanHepatitis A Virus Cellular Receptor 1Interleukin-18Membrane GlycoproteinsReceptors, Virus

Identifiers

PMID24005224
PMCPMC3880389
OpenAlexW2028597433

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.